July 29, 2016 2:01 PM ET

Company Overview of The Global Alliance for TB Drug Development

Key Executives for The Global Alliance for TB Drug Development

NameBoard RelationshipsTitleAge
Melvin K. Spigelman M.D.43 RelationshipsChief Executive Officer, President and Director67
Petro Terblanche 13 RelationshipsPresident of Stakeholders Association and Director--
Marshall Burke Ph.D.No RelationshipsSenior Vice President of External Affairs--
Dean R. Haubrich Ph.D.1 RelationshipsHead of Project Management --
Carl M. Mendel M.D., Ph.D.No RelationshipsSenior Vice President of Research and Development61
View More Key Executives

The Global Alliance for TB Drug Development Board Members*

NameBoard RelationshipsPrimary CompanyAge
Bruce L. A. Carter Ph.D. 182 RelationshipsEnanta Pharmaceuticals, Inc.73
Melvin K. Spigelman M.D. 43 RelationshipsThe Global Alliance for TB Drug Development67
Petro Terblanche 13 RelationshipsThe Global Alliance for TB Drug Development--
Mark Kessel J.D. 26 RelationshipsSymphony Capital LLC74
Anthony MBewu 9 RelationshipsThe Global Alliance for TB Drug Development--
View All Board Members

The Global Alliance for TB Drug Development Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range

INDUSTRY EXECUTIVE CHANGES

There is no Executive Change data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The Global Alliance for TB Drug Development, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.